Latest Expert Opinions

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
July 13, 2005
As a rule, he doesn't buy turn arounds. Prefers looking for the strongest company in the industry, not the weakest.
As a rule, he doesn't buy turn arounds. Prefers looking for the strongest company in the industry, not the weakest.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$2.860
Owned
No
DON'T BUY
DON'T BUY
July 13, 2005
Growth rate went from 30% three years ago to almost low single digits or flat. Not performing well. The group is in the early stages of a turn around, but would be more inclined to buy the company that has flourished through this period. Would prefer Abbott Labs (ABT-N).
Pfizer Inc (PFE-N)
July 13, 2005
Growth rate went from 30% three years ago to almost low single digits or flat. Not performing well. The group is in the early stages of a turn around, but would be more inclined to buy the company that has flourished through this period. Would prefer Abbott Labs (ABT-N).
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$27.230
Owned
No
DON'T BUY
DON'T BUY
July 13, 2005
A laggard in an industry that's been doing pretty well. There's better places to be. Would consider something that's more focused on nickel or copper.
Alcan Aluminum (AL-T)
July 13, 2005
A laggard in an industry that's been doing pretty well. There's better places to be. Would consider something that's more focused on nickel or copper.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$38.420
Owned
No
BUY
BUY
July 13, 2005
The biotech sector is one of the first growth oriented groups that turned up and has been relatively strong all year. Likes this one because it has a diversified revenue line. Growing cash flow.
Genentech (DNA-N)
July 13, 2005
The biotech sector is one of the first growth oriented groups that turned up and has been relatively strong all year. Likes this one because it has a diversified revenue line. Growing cash flow.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$86.650
Owned
Yes
DON'T BUY
DON'T BUY
July 13, 2005
One of the concerns that he does have about the market is that the transport group is under performing the industrials and the utilities. Probably has to do with high energy costs. Probably the best run railroad in North America.
One of the concerns that he does have about the market is that the transport group is under performing the industrials and the utilities. Probably has to do with high energy costs. Probably the best run railroad in North America.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$70.870
Owned
No
DON'T BUY
DON'T BUY
July 13, 2005
He doesn't buy stocks in decline and tries not to buy turnarounds. This one is getting to a point where some of the uncertainty is coming out of the company. However, they've had to make so many cuts, you wonder how they are going to fare with a significant decrease in R&D spending.
Nortel (NT-T)
July 13, 2005
He doesn't buy stocks in decline and tries not to buy turnarounds. This one is getting to a point where some of the uncertainty is coming out of the company. However, they've had to make so many cuts, you wonder how they are going to fare with a significant decrease in R&D spending.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$3.370
Owned
No
DON'T BUY
DON'T BUY
July 13, 2005
There's no sign whatsoever that they've got this thing turned around. Very little in the Canadian health care sector that looks good.
Patheon (PTI-T)
July 13, 2005
There's no sign whatsoever that they've got this thing turned around. Very little in the Canadian health care sector that looks good.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$9.100
Owned
No